Currently, 10 ongoing pilot projects involve up to 100 national authorities. These pilots primarily address major manufacturing changes, aimimg to minimize potential disruptions in the supply of medicines and vaccines.

Source:

EMA: Reliance for post-authorisation changes: pilots for the pharmaceutical industry

Meet the GMP Compliance Adviser.

The GMP Compliance Adviser is the world's largest knowledge portal for quality management in the pharma business.

The demo access is non-binding and ends automatically.

>>> Test it now for free